Pharmacologic options for the treatment and management of food allergy.

about

Food Allergy: Our Evolving Understanding of Its Pathogenesis, Prevention, and Treatment.

P2860

Q35978762-4DE4A645-6947-4ED7-9A6B-2D803D907532

P2860

Pharmacologic options for the treatment and management of food allergy.

Item

http://www.wikidata.org/entity/Q38569684

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Pharmacologic options for the treatment and management of food allergy.

@en

type

Item

label

Pharmacologic options for the treatment and management of food allergy.

@en

prefLabel

Pharmacologic options for the treatment and management of food allergy.

@en

P1476

Pharmacologic options for the treatment and management of food allergy.

@en

P2093

A Wesley Burks

http://www.w3.org/2001/XMLSchema#string

Aaron K Kobernick

http://www.w3.org/2001/XMLSchema#string

Jeffrey Chambliss

http://www.w3.org/2001/XMLSchema#string

P2860

Epicutaneous immunotherapy (EPIT) blocks the allergic esophago-gastro-enteropathy induced by sustained oral exposure to peanuts in sensitized mice

Food allergy: Epidemiology, pathogenesis, diagnosis, and treatment.

Novel strategy to create hypoallergenic peanut protein-polyphenol edible matrices for oral immunotherapy.

Peanut oral immunotherapy results in increased antigen-induced regulatory T-cell function and hypomethylation of forkhead box protein 3 (FOXP3).

Oral delivery of Brucella spp. recombinant protein U-Omp16 abrogates the IgE-mediated milk allergy

Safety and feasibility of oral immunotherapy to multiple allergens for food allergy.

Individualized IgE-based dosing of egg oral immunotherapy and the development of tolerance.

Food Allergy Herbal Formula-1 (FAHF-1) blocks peanut-induced anaphylaxis in a murine model.

Safety, tolerability, and immunologic effects of a food allergy herbal formula in food allergic individuals: a randomized, double-blinded, placebo-controlled, dose escalation, phase 1 study.

The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice.

P304

623-633

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1586/17512433.2015.1074038

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26289224

http://www.w3.org/2001/XMLSchema#string

Pharmacologic options for the treatment and management of food allergy.

about

P2860

P2860

Pharmacologic options for the treatment and management of food allergy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698